Manage your personalised Watchlist.Set up an online Virtual Portfolio.Participate in Share Chat.See more trades and director dealings.Play the Fantasy Share Trading Game.
Register for FREE Now
Posted in: GDR
Personally believe that is a long way off. October time. As winter approaches and the virus grips Europe once more sentiment will return and with it a buyount SP. Hopefully that gives them enough time to work out how to close a deal and secure actual contracts in target markets not deals in principle...
Lool what has he said? To be honest they need to know the heat is on. The SP has been butchered of late.
Yeh I'm holding. There are serious question marks over their sales ability but what initially attracted me was the ambient temperature of the product and single mix, which logically, should benefit African/Indian states.
Yes, I'd of been off in a shot had I 10 bagged there. No profit taki g at all? I initially bought in at 28 and sold in the 50s.Mugs game AIM.
easy to hold when you're in profit. I'm 35% down after lowering my average 4 times. I got killed on my entry, only myself to blame there. That placing has done nobody any favours mind.
Sam,My personal belief is in the EU or USPs are not as advantageous as we initially thought. EU have the lab infrastructure & personel to operate their current test preferences. Equally we missed the entire first wave in Europe and they will have deep ties with test providers now. Our USPs are suited to warmer climates with lower built infrastructure I guess. It is disappointing but that's my view on EU. Perhaps it maybe change.
Nio... is the ticker... Can we not go back to discussing other stocks on this board. Pathetic enough today.
I'm p issed off because they haven't told us where these orders were placed. If in a target of India or America this RNS is entirely different. Perhaps they can not say due to approval status but it is frustrating.
Lol I moaned at the rns as was slightly underwhelming but I've topped up. Well overdone, its progress. All I wanted.
Lol top man... initial engagements have immidiately led then to further adapt their offering. Its lack of understanding not commercial brilliance that's led to new software being developed. You lot spin anything.
Certainly agree it is primed to rerate heavily upon further substantial sales. And it is positive to know that countries see the value following review periods to purchase.
Lb come on. 1m is below expectations. And not actually finalized. They've stated commercial efforts focused on india and usa where we are awaiting approval... so why send it to european countries then...Then they've sent out a following rns to sweeten the blow. I'll call it how I see it. Below average progress for the supposed best test on the market.
Would of liked to know where those orders came from. Poor all in all I must say but at least we have clarity. Gunna be a long wait.
Page 10.. Go into a dark room mate, take your cum sock with you and login to your favourite cam site and relieve yourself LB. There has to be a better way to spend your time.
Scary, appreciate the clarification. Even if still a bit of time away to purchase this is great news. Progress, all we want to see.
Bobby, if you watch the recent presentation there is a slide dedicated to competitor analysis. Novacyts test is included. You'll find it on YouTube.
What a pathetic waste of yours and everyone's time.
Lol yet red.
Right, someone take his lolly. Not even copy and paste properly. Simply lazy. Come on Punit